When ordering COVID-19 laboratory tests or collecting specimens, health care providers should collect certain patient demographic information and responses to certain questions needed for COVID-19 data reporting, according to updated guidance from the Centers for Disease Control and Prevention.

“These data elements are critical for the COVID-19 public health response, and including them with test orders enable the laboratories that perform the test to report the information to state and jurisdictional health departments, as required,” the guidance states.

For more information, see the Department of Health and Human Services recent guidance and FAQs on hospital data reporting.

Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…